Page 361 - ATP-P 11th Ed

JDF Status Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes (continues)

Controlled No No No No No No No No No No No No No No Yes

Recommended NDC 00409155554 00264196510 53746013105 53746013705 00173059500 00045006801 00045006951 00045152510 00186012001 51079069020 00004017202 00597003001 00338105548 00182133089 10019017963

NSN 6505014988636 6505012811247 6505001288035 6505012149062 6505014629945 6505014974346 6505014448356 6505014446635 6505005986117 6505012385632 6505013151275 6505015413243 6505014626450 6505011424914 6505011533284 SECTION 3

AHFS Category replacement preparations replacement preparations other nonsteroidal anti-inflammatory agents other nonsteroidal anti-inflammatory agents nucleoside and nucleotide reverse transcriptase inhibitors quinolones quinolones quinolones local anesthetics antidiarrhea agents

MASTER DRUG LIST (cont.) Nomenclature Common Name hetastarch 6% in hetastarch 6% in lactated electrolytes lactated electrolytes 500mL plastic bag 12s (Hextend) 500mL hetastarch 6% in hetastarch 6% in sodium chloride sodium chloride 500mL plastic bag (Hespan) 500mL (Hespan) 12s plastic bag 12s i

levofloxacin
levofloxacin
capsules 60s
plastic bag
25mg/mL
I.S. 100s
20mL
500s
levofloxacin (Xylocaine) 2% injection loperamide mefloquine ATP-P Handbook 11th Edition 351